Matthew T. David M.D.
Net Worth
Last updated:
What is Matthew T. David M.D. net worth?
The estimated net worth of Dr. Matthew T. David M.D. is at least $2,250,939 as of 6 Dec 2021. He owns shares worth $41,139 as insider and has received compensation worth at least $2,209,800 in CorMedix Inc..
What is the salary of Matthew T. David M.D.?
Dr. Matthew T. David M.D. salary is $441,960 per year as Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer in CorMedix Inc..
How old is Matthew T. David M.D.?
Dr. Matthew T. David M.D. is 47 years old, born in 1978.
What stocks does Matthew T. David M.D. currently own?
As insider, Dr. Matthew T. David M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| CorMedix Inc. (CRMD) | Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer | 3,150 | $13.06 | $41,139 |
What does CorMedix Inc. do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Matthew T. David M.D. insider trading
CorMedix key executives
CorMedix Inc. executives and other stock owners filed with the SEC:
- Dr. Matthew T. David M.D. (47) Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer
- Dr. Phoebe Mounts Esq. (75) Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal
- Ms. Elizabeth Masson-Hurlburt (46) Executive Vice President & Head of Clinical Operations